Breakdown of tolerance to the intestinal bacterial flora in inflammatory bowel disease (IBD).
作者信息
MacDonald T T
出版信息
Clin Exp Immunol. 1995 Dec;102(3):445-7. doi: 10.1111/j.1365-2249.1995.tb03835.x.
Abstract
摘要
相似文献
1
Breakdown of tolerance to the intestinal bacterial flora in inflammatory bowel disease (IBD).
Clin Exp Immunol. 1995 Dec;102(3):445-7. doi: 10.1111/j.1365-2249.1995.tb03835.x.
2
Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD).
Clin Exp Immunol. 1995 Dec;102(3):448-55. doi: 10.1111/j.1365-2249.1995.tb03836.x.
3
Layers of mutualism with commensal bacteria protect us from intestinal inflammation.
Gut. 2006 Feb;55(2):276-84. doi: 10.1136/gut.2004.054098.
4
Intestinal flora and mucosal immune responses.
Int J Med Microbiol. 2003 Apr;293(1):77-86. doi: 10.1078/1438-4221-00246.
5
The pathogenic role of intestinal flora in IBD and colon cancer.
Curr Drug Targets. 2008 May;9(5):395-403. doi: 10.2174/138945008784221125.
6
Gut biofilm forming bacteria in inflammatory bowel disease.
Microb Pathog. 2017 Nov;112:5-14. doi: 10.1016/j.micpath.2017.09.041. Epub 2017 Sep 20.
7
Immunoglobulin coating of faecal bacteria in inflammatory bowel disease.
Eur J Gastroenterol Hepatol. 2004 Jul;16(7):669-74. doi: 10.1097/01.meg.0000108346.41221.19.
8
Is diet a factor in the pathogenesis of IBD?
Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S35-6. doi: 10.1002/ibd.20547.
9
Role of commensal enteric bacteria in the pathogenesis of immune-mediated intestinal inflammation: lessons from animal models and implications for translational research.
J Pediatr Gastroenterol Nutr. 2005 Apr;40 Suppl 1:S30-1. doi: 10.1097/00005176-200504001-00018.
10
Helminths and Intestinal Flora Team Up to Improve Gut Health.
Trends Parasitol. 2016 Sep;32(9):664-666. doi: 10.1016/j.pt.2016.05.006. Epub 2016 May 24.
引用本文的文献
1
Recent Updates on the Therapeutics Benefits, Clinical Trials, and Novel Delivery Systems of Chlorogenic Acid for the Management of Diseases with a Special Emphasis on Ulcerative Colitis.
Curr Pharm Des. 2024;30(6):420-439. doi: 10.2174/0113816128295753240129074035.
2
As a Versatile Vehicle for Tolerogenic Immunotherapy.
Front Immunol. 2018 Jan 17;8:1961. doi: 10.3389/fimmu.2017.01961. eCollection 2017.
3
Hsp65-Producing Prevents Inflammatory Intestinal Disease in Mice by IL-10- and TLR2-Dependent Pathways.
Front Immunol. 2017 Jan 30;8:30. doi: 10.3389/fimmu.2017.00030. eCollection 2017.
4
Elemental diet and the nutritional treatment of Crohn's disease.
Gastroenterol Hepatol Bed Bench. 2015 Winter;8(1):4-5.
5
Deficiency of invariant NK T cells in Crohn's disease and ulcerative colitis.
Dig Dis Sci. 2007 Jun;52(6):1415-22. doi: 10.1007/s10620-006-9261-7. Epub 2007 Apr 10.
6
Kawasaki disease may be a hyperimmune reaction of genetically susceptible children to variants of normal environmental flora.
Med Hypotheses. 2007;69(3):642-51. doi: 10.1016/j.mehy.2006.12.051. Epub 2007 Mar 6.
7
Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells.
Gut. 2005 Feb;54(2):228-36. doi: 10.1136/gut.2004.040360.
8
Macroscopic, microscopic and biochemical characterisation of spontaneous colitis in a transgenic mouse, deficient in the multiple drug resistance 1a gene.
Br J Pharmacol. 2004 Nov;143(5):590-8. doi: 10.1038/sj.bjp.0705982. Epub 2004 Oct 4.
9
Monocyte/macrophage activation by normal bacteria and bacterial products: implications for altered epithelial function in Crohn's disease.
Am J Pathol. 2001 Mar;158(3):1101-9. doi: 10.1016/S0002-9440(10)64057-6.
10
Experimental colitis induced by trinitrobenzenesulfonic acid: an ultrastructural and histochemical study.
Dig Dis Sci. 1999 Dec;44(12):2523-9. doi: 10.1023/a:1026651408998.
本文引用的文献
1
Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD).
Clin Exp Immunol. 1995 Dec;102(3):448-55. doi: 10.1111/j.1365-2249.1995.tb03836.x.
2
Interleukin-10-deficient mice develop chronic enterocolitis.
Cell. 1993 Oct 22;75(2):263-74. doi: 10.1016/0092-8674(93)80068-p.
3
Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene.
Cell. 1993 Oct 22;75(2):253-61. doi: 10.1016/0092-8674(93)80067-o.
4
Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection.
Gastroenterology. 1995 Jun;108(6):1617-21. doi: 10.1016/0016-5085(95)90121-3.
5
Mucosal injury and inflammation in a model of chronic granulomatous colitis in rats.
Gastroenterology. 1993 Mar;104(3):759-71. doi: 10.1016/0016-5085(93)91011-6.
6
The presence of peptidoglycan-polysaccharide complexes in the bowel wall and the cellular responses to these complexes in Crohn's disease.
Clin Immunol Immunopathol. 1994 Jun;71(3):303-8. doi: 10.1006/clin.1994.1090.
7
The faecal flora of patients with Crohn's disease.
J Hyg (Lond). 1981 Aug;87(1):1-12. doi: 10.1017/s0022172400069187.
8
Mechanisms confining indigenous bacteria to the gastrointestinal tract.
Am J Clin Nutr. 1980 Nov;33(11 Suppl):2472-84. doi: 10.1093/ajcn/33.11.2472.
9
The microbiota of the gastrointestinal tract.
Gastroenterology. 1966 Nov;51(5):868-74.
10
Electron microscopy in Crohn's disease.
Gut. 1971 Jul;12(7):509-18. doi: 10.1136/gut.12.7.509.
Zotero 插件